State Street
DNA icon

State Street’s Ginkgo Bioworks DNA Stock Holding History

State Street’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.6M Buy
1,472,370
+125,711
+9% +$1.05M ﹤0.01% 2525
2026
Q1 		$8.26M Buy
1,346,659
+54,588
+4% +$454K ﹤0.01% 2714
2025
Q4 		$10.7M Buy
1,292,071
+358,231
+38% +$3.86M ﹤0.01% 2615
2025
Q3 		$13.6M Buy
933,840
+192,788
+26% +$2.31M ﹤0.01% 2449
2025
Q2 		$8.34M Buy
741,052
+405,682
+121% +$3.14M ﹤0.01% 2694
2025
Q1 		$1.91M Buy
335,370
+96,541
+40% +$984K ﹤0.01% 3262
2024
Q4 		$2.35M Buy
238,829
+22,808
+11% +$195K ﹤0.01% 3266
2024
Q3 		$1.76M Sell
216,021
-36,296
-14% -$364K ﹤0.01% 3363
2024
Q2 		$3.37M Sell
252,317
-412,320
-62% -$12.3M ﹤0.01% 3091
2024
Q1 		$30.8M Buy
664,637
+13,296
+2% +$688K ﹤0.01% 1973
2023
Q4 		$44M Buy
651,341
+89,998
+16% +$5.51M ﹤0.01% 1774
2023
Q3 		$40.6M Buy
561,343
+44,249
+9% +$3.54M ﹤0.01% 1748
2023
Q2 		$38.5M Buy
517,094
+149,406
+41% +$8.84M ﹤0.01% 1827
2023
Q1 		$19.6M Buy
367,688
+20,025
+6% +$1.27M ﹤0.01% 2248
2022
Q4 		$23.5M Buy
347,663
+17,896
+5% +$1.65M ﹤0.01% 2124
2022
Q3 		$41.2M Buy
329,767
+19,471
+6% +$2.32M ﹤0.01% 1732
2022
Q2 		$29.5M Buy
310,296
+210,294
+210% +$25.6M ﹤0.01% 1970
2022
Q1 		$16.1M Buy
100,002
+5,060
+5% +$985K ﹤0.01% 2545
2021
Q4 		$31.6M Buy
+94,942
New +$45.1M ﹤0.01% 2137

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street's DNA Position: Q2 2026 in Review

State Street increased its Ginkgo Bioworks (DNA) stake by 9.3% in Q2 2026, buying an estimated $1.05M and bringing the position to 1,472,370 shares worth $14.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2525.

State Street first reported a position in DNA in Q4 2021 and has held it in 19 quarters since. The position peaked at $44M in Q4 2023. 184 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • State Street held 1,472,370 shares of Ginkgo Bioworks worth $14.6M as of Q2 2026.
  • State Street bought 125,711 Ginkgo Bioworks shares in Q2 2026, an estimated $1.05M.
  • Ginkgo Bioworks made up ﹤0.01% of State Street's portfolio in Q2 2026, its #2525 holding.
  • State Street first reported a position in Ginkgo Bioworks in Q4 2021 and has held it in 19 quarters since.
  • State Street's Ginkgo Bioworks position peaked at $44M in Q4 2023.
  • 184 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.